Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?

@article{Pisu2009PharmaceuticalsCM,
  title={Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?},
  author={Maria Pisu and Joshua S. Richman and Jeroan J. Allison and O. Dale Williams and Catarina I. Kiefe},
  journal={Southern medical journal},
  year={2009},
  volume={102 2},
  pages={
          139-44
        }
}
OBJECTIVES This study examined how physicians perceive pharmaceutical companies' medication assistance programs (MAPs). METHODS The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot afford drugs, and barriers to using them. Bivariate associations between physician-level variables… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-5 of 5 extracted citations

Comparison of patient assistance program software.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2011
View 4 Excerpts
Highly Influenced

Effect of a patient support program on access to oral therapy for hematologic malignancies.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists • 2012
View 2 Excerpts